Cargando…
Heterogeneity of national legislation and practice on clinical trials with vulnerable patients based on the EU Clinical Trials Directive by the example of adults permanently incapable of giving informed consent
In principle, persons wishing to participate in a clinical trial must give informed consent in advance after comprehensive information has been provided. Under certain conditions, it is possible to deviate from this requirement in the European Union (EU) in order to enable the participation of so-ca...
Autores principales: | Schweim, Janna K., Nonnemacher, Michael, Jöckel, Karl-Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983012/ https://www.ncbi.nlm.nih.gov/pubmed/33796001 http://dx.doi.org/10.3205/000290 |
Ejemplares similares
-
Aspects of vulnerable patients and informed consent in clinical trials
por: Kuthning, Maria, et al.
Publicado: (2013) -
Are Parents of Preschool Children Inclined to Give Consent for Participation in Nutritional Clinical Trials?
por: Nimbalkar, Somashekhar Marutirao, et al.
Publicado: (2016) -
Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
por: Souto, Eliana B., et al.
Publicado: (2020) -
Legislation on research involving patients who are (temporarily) unable to give informed consent: differences between European countries
por: Kuiper, Michael A., et al.
Publicado: (2007) -
Consent concerns in clinical trials of investigational therapies for COVID-19: Vulnerability versus voluntariness
por: Bhatt, Arun
Publicado: (2020)